Nitroglycerin Sublingual (SL) Tablets   3

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79722R0002 for an unrestrictive procurement for Nitroglycerin Sublingual (SL) tablets for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation #36E79722R0002 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about November 12, 2021, with a tentative closing date of November 26, 2021. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL:https://sam.gov/content/home. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Stevan Vasich. Questions can be e-mailed to: Stevan.Vasich@va.gov. The estimated annual requirements are as follows: Item Description Size Estimated Annual Requirements (Bottles) Nitroglycerin 0.3 MG Tab, Sublingual 100 9,289 Nitroglycerin 0.4 MG Tab, Sublingual 100 235,476 3 Nitroglycerin 0.4 MG Tab, Sublingual 100 (4x25) 45,777 4 Nitroglycerin 0.6 MG Tab, Sublingual 100 1,377 *Line item three (3) contains four (4) bottles of 25 tablets each, while line item two (2) contains a single bottle of 100 tablets.